231 related articles for article (PubMed ID: 36906159)
1. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
Sun J; Tang L; Shan Y; Yu M; Sheng L; Huang L; Cao H; Dai H; Wang F; Zhao J; Sheng M
J Ethnopharmacol; 2023 Jun; 309():116343. PubMed ID: 36906159
[TBL] [Abstract][Full Text] [Related]
2. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
[TBL] [Abstract][Full Text] [Related]
3. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
4. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis.
Zhang XW; Wang L; Ding H
FASEB J; 2019 Apr; 33(4):5112-5125. PubMed ID: 30652956
[TBL] [Abstract][Full Text] [Related]
6. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of Danshenol C in reversing peritoneal fibrosis: novel network pharmacological analysis and biological validation.
Liang J; Cheng L; Feng J; Han Z; Huang C; Xie F; Li Y; Luo X; Wang Q; He J; Chen H
BMC Complement Med Ther; 2023 Oct; 23(1):361. PubMed ID: 37833759
[TBL] [Abstract][Full Text] [Related]
8. Involvement of STAT3 Signaling in High Glucose-Induced Epithelial Mesenchymal Transition in Human Peritoneal Mesothelial Cell Line HMrSV5.
Zhang P; Dai H; Peng L
Kidney Blood Press Res; 2019; 44(2):179-187. PubMed ID: 30943519
[TBL] [Abstract][Full Text] [Related]
9. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
[TBL] [Abstract][Full Text] [Related]
10. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis.
Zhang Y; Feng W; Peng X; Zhu L; Wang Z; Shen H; Chen C; Xiao L; Li S; Zhao Y; Lin M; Huang Y; Long H; Liang J
Lab Invest; 2022 Dec; 102(12):1346-1354. PubMed ID: 36307537
[TBL] [Abstract][Full Text] [Related]
12. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis.
Strippoli R; Sandoval P; Moreno-Vicente R; Rossi L; Battistelli C; Terri M; Pascual-Antón L; Loureiro M; Matteini F; Calvo E; Jiménez-Heffernan JA; Gómez MJ; Jiménez-Jiménez V; Sánchez-Cabo F; Vázquez J; Tripodi M; López-Cabrera M; Del Pozo MÁ
Cell Death Dis; 2020 Aug; 11(8):647. PubMed ID: 32811813
[TBL] [Abstract][Full Text] [Related]
13. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
Tan M; Wu D; Zhou Y; Duan B
J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
[TBL] [Abstract][Full Text] [Related]
14. Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells.
Miyake T; Sakai N; Tamai A; Sato K; Kamikawa Y; Miyagawa T; Ogura H; Yamamura Y; Oshima M; Nakagawa S; Sagara A; Shinozaki Y; Toyama T; Kitajima S; Hara A; Iwata Y; Shimizu M; Furuichi K; Kaneko S; Wada T
Sci Rep; 2020 Aug; 10(1):14292. PubMed ID: 32868830
[TBL] [Abstract][Full Text] [Related]
15. Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.
Zhang L; Li Z; He W; Xu L; Wang J; Shi J; Sheng M
Cell Physiol Biochem; 2015; 37(1):43-54. PubMed ID: 26278416
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibits mesothelial-mesenchymal transition and alleviates postoperative peritoneal adhesions by blocking the TGF-β1/PI3K/AKT pathway.
Li G; Ren Y; Li E; Deng K; Qu C; Zhang J; Zhang L; Wang X; Lian J; Zhou H; Wang Z; Shen T; Li X; Jiang Z
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117242. PubMed ID: 37777024
[TBL] [Abstract][Full Text] [Related]
17. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis.
Sakai N; Nakamura M; Lipson KE; Miyake T; Kamikawa Y; Sagara A; Shinozaki Y; Kitajima S; Toyama T; Hara A; Iwata Y; Shimizu M; Furuichi K; Kaneko S; Tager AM; Wada T
Sci Rep; 2017 Jul; 7(1):5392. PubMed ID: 28710437
[TBL] [Abstract][Full Text] [Related]
20. Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.
Han SM; Ryu HM; Suh J; Lee KJ; Choi SY; Choi S; Kim YL; Huh JY; Ha H
Sci Rep; 2019 Feb; 9(1):1497. PubMed ID: 30728376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
